Thermo Fisher Acquisitions Help Meet COVID-19 and Other Disease Testing Demands
Thermo Fisher Scientific Inc. has entered into a definitive agreement to acquire Mesa Biotech, Inc., a privately held molecular diagnostic company, for approximately $450 million in cash. Keep Reading